Atlas Trials

BreakBio Corp

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch BreakBio Corp

RecordFirmDate
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy (NCT07762703)BreakBio Corp2026-09-01
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy (NCT07762716)BreakBio Corp2026-09-01

Track BreakBio Corp automatically

Every clearance here is in the API, with alerts when new ones post.